Ετικέτες

Τρίτη 19 Ιουνίου 2018

Simplified 4‐item criteria for polycystic ovary syndrome: A bridge too far?

Clinical Endocrinology, EarlyView.


https://ift.tt/2MGcU3V

Outcomes of Bethesda categories III and IV thyroid nodules over 5 years and performance of the Afirma gene expression classifier: A single‐institution study

Clinical Endocrinology, EarlyView.


https://ift.tt/2K4I1UM

Pharmacological and surgical treatment of nonreproductive outcomes in polycystic ovary syndrome: An overview of systematic reviews

Clinical Endocrinology, EarlyView.


https://ift.tt/2MH6XDF

Are pregnancy, parity, menstruation and breastfeeding risk factors for thyroid cancer? Results from the Korea National Health and Nutrition Examination Survey, 2010‐2015

Clinical Endocrinology, EarlyView.


https://ift.tt/2K02mdU

Assessment and management of bone health in women with oestrogen receptor‐positive breast cancer receiving endocrine therapy: Position statement of the Endocrine Society of Australia, the Australian and New Zealand Bone & Mineral Society, the Australasian Menopause Society and the Clinical Oncology Society of Australia

Clinical Endocrinology, EarlyView.


https://ift.tt/2MH4NnN

A novel mutation in KHDRBS1 in a patient affected by primary ovarian insufficiency

Clinical Endocrinology, EarlyView.


https://ift.tt/2M6Al50

Prospective evaluation of 68Ga‐DOTATATE PET/CT in limited disease neuroendocrine tumours and/or elevated serum neuroendocrine biomarkers

Clinical Endocrinology, EarlyView.


https://ift.tt/2MDZQvC

Issue Information ‐ Instructions for Authors

Clinical Endocrinology, Volume 89, Issue 1, Page 114-115, July 2018.


https://ift.tt/2JXULwI

Issue Information ‐ TOC and Editorial Board

Clinical Endocrinology, Volume 89, Issue 1, Page 1-2, July 2018.


https://ift.tt/2JSf6Yf

Recurrent orogenital erythema multiforme and vulval neutrophilic dermatosis

Australasian Journal of Dermatology, EarlyView.


https://ift.tt/2JTP9r2

Nonhealing ulcers in a young male

Australasian Journal of Dermatology, EarlyView.


https://ift.tt/2I3l6HV

Lichenoid drug eruption in a child with Turner syndrome: A rare adverse reaction of recombinant human growth hormone

Australasian Journal of Dermatology, EarlyView.


https://ift.tt/2tbyZ1U

Hand‐like periungual fibrokeratoma

Australasian Journal of Dermatology, EarlyView.


https://ift.tt/2M5ETsv

Eczematous reactions mimicking psoriasiform dermatitis induced by nivolumab for advanced lung cancer

Australasian Journal of Dermatology, EarlyView.


https://ift.tt/2taBUYS

Dermal duct tumour with ductal and sebaceous differentiation

Australasian Journal of Dermatology, EarlyView.


https://ift.tt/2M4z3Yh

Botulinum toxin type A for the first‐line treatment of Hailey–Hailey disease

Australasian Journal of Dermatology, EarlyView.


https://ift.tt/2JNfvLo

Frontal fibrosing alopecia: Regrowth following cessation of sunscreen on the forehead

Australasian Journal of Dermatology, EarlyView.


https://ift.tt/2I3daGz

Pyrrolnitrin is more essential than phenazines for Pseudomonas chlororaphis G05 in its suppression of Fusarium graminearum

S09445013.gif

Publication date: Available online 18 June 2018
Source:Microbiological Research
Author(s): Run Huang, Zhibin Feng, Xiaoyan Chi, Xiaoqiang Sun, Yang Lu, Baoshen Zhang, Ruiyang Lu, Wangtai Luo, Yanhua Wang, Jing Miao, Yihe Ge
Fusarium graminearum is the major causal agent of Fusarium head blight (FHB) disease in cereal crops worldwide. Infection with this fungal phytopathogen can regularly cause severe yield and quality losses and mycotoxin contamination in grains. In previous other studies, one research group reported that pyrrolnitrin had an ability to suppress of mycelial growth of F. graminearum. Other groups revealed that phenazine-1-carboxamide, a derivative of phenazine-1-carboxylic acid, could also inhibit the growth of F. graminearum and showed great potentials in the bioprotection of crops from FHB disease. In our recent work with Pseudomonas chlororaphis strain G05, however, we found that although the phz operon (phenazine biosynthetic gene cluster) was knocked out, the phenazine-deficient mutant G05Δphz still exhibited effective inhibition of the mycelial growth of some fungal phytopathogens in pathogen inhibition assay, especially including F. graminearum, Colletotrichum gloeosporioides, Botrytis cintrea. With our further investigations, including deletion and complementation of the prn operon (pyrrolnitrin biosynthetic gene cluster), purification and identification of fungal compounds, we first verified that not phenazines but pyrrolnitrin biosynthesized in P. chlororaphis G05 plays an essential role in growth suppression of F. graminearum and the bioprotection of cereal crops against FHB disease.



https://ift.tt/2taWbxu

Comparison of tissue loss by different punches: A new A‐design

Journal of Cosmetic Dermatology, EarlyView.


https://ift.tt/2JRa91F

Dual functional bioactive‐peptide, AIMP1‐derived peptide (AdP), for anti‐aging

Journal of Cosmetic Dermatology, EarlyView.


https://ift.tt/2tayrJQ

Αναζήτηση αυτού του ιστολογίου